Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,010.31
-4.18 (-0.41%)
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
↗
November 12, 2025
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
Via
Benzinga
Why Metsera's Share Price Is Plummeting This Week
↗
November 12, 2025
The biotech start-up's stock had been rising rapidly in 2025.
Via
The Motley Fool
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?
↗
November 12, 2025
This drugmaker's innovation engine continues to operate at full capacity.
Via
The Motley Fool
Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power
↗
November 12, 2025
Lilly is reportedly shifting its 50,000 employees to Rightway, a fintech-driven pharmacy benefit manager, starting January 1.
Via
Stocktwits
Elon Musk Finds It ‘Cool’ That Eli Lilly CEO Uses Grok As One Of His Daily Advisors
↗
November 11, 2025
Via
Stocktwits
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle?
↗
November 10, 2025
Via
Stocktwits
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
↗
November 11, 2025
Via
Stocktwits
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
November 11, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...
Via
StockStory
Topics
Stocks
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 11, 2025
Via
Benzinga
Three Healthcare Buys That Wall Street Loves
↗
November 11, 2025
These three healthcare stocks are outperforming most of the sector.
Via
The Motley Fool
These 20 Stocks Now Make Up Half Of The S&P 500—Here's Why That's Risky
↗
November 11, 2025
A new report shows the S&P 500 is now more concentrated than ever, with 20 companies making up over 50% of its value, driven by AI hype, not earnings.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
↗
November 11, 2025
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.
Via
The Motley Fool
2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds
November 10, 2025
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...
Via
StockStory
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
November 10, 2025
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Here's How Much $100 Invested In Eli Lilly 15 Years Ago Would Be Worth Today
↗
November 10, 2025
Via
Benzinga
Eli Lilly Stock Surges As Analyst Sees More Room To Run
↗
November 10, 2025
Eli Lilly shares are rising Monday after Leerink Partners upgraded the stock to Outperform and raised its price target to $1,104.
Via
Benzinga
Tech Titans Lead the Charge: A Deep Dive into Sector Performance in the Current Market Rally
November 10, 2025
The stock market, as of November 10, 2025, continues its robust rally, defying earlier recessionary fears and exhibiting significant growth across several key sectors. At the heart of this resurgence...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Why Eli Lilly (LLY) Stock Is Trading Up Today
November 10, 2025
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.9% in the afternoon session after Leerink Partners upgraded the stock to Outperform from Market Perform and significantly raised...
Via
StockStory
Topics
Artificial Intelligence
Stay informed with the top movers within the S&P500 index on Monday.
↗
November 10, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
Markets Cheer As Shutdown End Nears: These 15 Stocks Are Rallying
↗
November 10, 2025
Markets rallied sharply Monday morning as Congress edged closer to a deal that could end the longest U.S. government shutdown in history.
Via
Benzinga
Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration
↗
November 10, 2025
MeiraGTx shares rise after signing a $475 million deal with Eli Lilly for a gene therapy program restoring vision in children with LCA4.
Via
Benzinga
This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
November 10, 2025
Via
Benzinga
Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday
↗
November 10, 2025
Via
Benzinga
12 Analysts Have This To Say About Eli Lilly
↗
November 10, 2025
Via
Benzinga
This Eli Lilly Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
↗
November 10, 2025
Via
Benzinga
2 Monster Stocks in the Making
↗
November 10, 2025
There might still be time to get in on the ground floor.
Via
The Motley Fool
2 Growth Stocks with All-Star Potential and 1 We Question
November 09, 2025
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...
Via
StockStory
3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs
↗
November 09, 2025
For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.
Via
The Motley Fool
The Algorithmic Imperative: Navigating AI’s Ethical Labyrinth in American Healthcare
November 09, 2025
As of November 2025, Artificial Intelligence (AI) has rapidly transitioned from a futuristic concept to an indispensable tool in American healthcare, profoundly reshaping diagnostics, treatment, and...
Via
TokenRing AI
Topics
Artificial Intelligence
Is There a Future for Viking Therapeutics?
↗
November 09, 2025
The weight loss drug company was counted out far too early in the summer, but investors are warming to it again.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today